PDT Partners’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-4,806
| Closed | -$490K | – | 708 |
|
|
2023
Q2 | $490K | Sell |
4,806
-38,343
| -89% | -$3.91M | 0.07% | 381 |
|
|
2023
Q1 | $3.92M | Buy |
43,149
+5
| +0% | +$455 | 0.53% | 21 |
|
|
2022
Q4 | $1.64M | Sell |
43,144
-14,990
| -26% | -$569K | 0.27% | 120 |
|
|
2022
Q3 | $1.46M | Sell |
58,134
-5,130
| -8% | -$129K | 0.22% | 127 |
|
|
2022
Q2 | $1.92M | Buy |
63,264
+52,907
| +511% | +$1.61M | 0.17% | 183 |
|
|
2022
Q1 | $339K | Buy |
+10,357
| New | +$339K | 0.03% | 686 |
|